Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Abstract
The most sensitive existing assays used to determine antibody levels in blood serum samples require a tracer material, e.g., radioisotope, fluorofore, or enzyme, to identify the specific analyte. Surface plasmon spectroscopy has been applied recently as a no-label technique for the assay of specific antibody solutions with the antigen proteins immobilized on a metal surface. It is found that the metal surface configuration originally proposed for the surface plasmon immunoassay (SPI) is unstable and unsuitable for the assay of specific antibodies in a large mixture of proteins such as in a blood serum. Nevertheless, by properly designing the metal surface structure, the SPI can be made an extremely practical device. Preliminary results for the assay of dinitrophenyl (DNP) and keyhole limpet hemocyanin (KLH) antibodies in blood serum samples, indicate that the SPI, in addition to providing a simple and fast measurement, is comparable with existing approaches, such as radioimmunoassy or enzyme-linked immunosorbent assay both in sensitivity and specificity.
View details for Web of Science ID A1990EJ48300035
View details for PubMedID 20577453